Second COVID-19 Vaccine Undergoes ‘Rolling Review’ By EMA

 
• By Neena Brizmohun

The European Medicines Agency is fast-tracking its review of the vaccine that BioNTech and Pfizer are developing and testing in Phase III trials.

Injection
COVID-19: the BNT162b2 vaccine is being tested in a global Phase III study • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards